BioAge Labs (BIOA) shares were up over 13% in recent Wednesday trading after Citigroup upgraded the stock to buy from neutral and boosted its price target to $10 from $5.
Trading volume stood at more than 1.0 million shares, compared with a daily average of about 167,000.
Price: 6.00, Change: +0.70, Percent Change: +13.21